Mach7 Technologies (ASX:M7T) FCF Margin % : -1.92% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Mach7 Technologies's Free Cash Flow for the six months ended in Dec. 2023 was A$-0.26 Mil. Mach7 Technologies's Revenue for the six months ended in Dec. 2023 was A$13.33 Mil. Therefore, Mach7 Technologies's FCF Margin % for the quarter that ended in Dec. 2023 was -1.92%.

As of today, Mach7 Technologies's current FCF Yield % is 1.30%.

The historical rank and industry rank for Mach7 Technologies's FCF Margin % or its related term are showing as below:

ASX:M7T' s FCF Margin % Range Over the Past 10 Years
Min: -1579.86 Med: -26.27 Max: 31.89
Current: 12.25

During the past 13 years, the highest FCF Margin % of Mach7 Technologies was 31.89%. The lowest was -1579.86%. And the median was -26.27%.

ASX:M7T's FCF Margin % is ranked better than
82.04% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 1.26 vs ASX:M7T: 12.25

Mach7 Technologies FCF Margin % Historical Data

The historical data trend for Mach7 Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies FCF Margin % Chart

Mach7 Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

-32.02

24.76

7.34

31.89

-14.68

Mach7 Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															7.22	114.73	-32.50	61.40	-1.92

Competitive Comparison of Mach7 Technologies's FCF Margin %

For the Health Information Services subindustry, Mach7 Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mach7 Technologies's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's FCF Margin % falls into.

Mach7 Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Mach7 Technologies's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-2.973	/	20.258
	=	-14.68 %

Mach7 Technologies's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.256	/	13.332
	=	-1.92 %

Mach7 Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mach7 Technologies (ASX:M7T) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403

Website

https://www.mach7t.com

Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies (ASX:M7T) Headlines

No Headlines